BiotechTube
Home/Imunexus Therapeutics/Chris Elliot
CE

Chris Elliot

Chief Financial Officer and Company Secretary

Imunexus Therapeutics

Therapeutic Areas

OncologyNeurologyRare Disease

Imunexus Therapeutics Pipeline

DrugIndicationPhase
IMX101Small Cell Lung CancerPreclinical
IMX113Rare Pediatric DiseasePreclinical
IMX39Multiple SclerosisPreclinical

Leadership Team at Imunexus Therapeutics

PL
Philippa Lewis
Executive Director and Chairperson
DB
Don Brumley
Non‑Executive Director
DG
Dr George Kopsidas
Chief Scientific Officer and Founder
View full Imunexus Therapeutics profile